Priorix Kit
NDC Package 58160-824-15
Package Information
Priorix (measels, mumps, and rubella vaccine, live) kits is pRIORIX is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. This formulation utilizes a kit delivery system. Marketed by Glaxosmithkline Biologicals Sa, this product is identified by NDC 58160-824 and is authorized under FDA application BLA125748.
Identification & Billing
- RxCUI: 2603508 - measles, mumps, and rubella virus vaccine live (generic for Priorix) 0.5 ML Injection
- RxCUI: 2603508 - 0.5 ML measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection
- RxCUI: 2603514 - PRIORIX vaccine 0.5 ML Injection
- RxCUI: 2603514 - 0.5 ML measles virus vaccine live, attenuated Schwarz strain 5024 UNT/ML / mumps virus vaccine live, RIT-4385 strain 31684 UNT/ML / rubella virus vaccine live (Wistar RA 27-3 strain) 3990 UNT/ML Injection [Priorix]
- RxCUI: 2603514 - Priorix Measles, Mumps, and Rubella Virus Vaccine Live 0.5 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 58160 - Glaxosmithkline Biologicals Sa
- 58160-824 - Priorix
- 58160-824-15 - 1 KIT in 1 CARTON * .5 mL in 1 VIAL (58160-831-03) * .5 mL in 1 SYRINGE (58160-833-02)
- 58160-824 - Priorix
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58160-824-15 identifies a specific commercial package of 1 kit in 1 carton * .5 ml in 1 vial (58160-831-03) * .5 ml in 1 syringe (58160-833-02) of Priorix, a vaccine label labeled by Glaxosmithkline Biologicals Sa. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glaxosmithkline Biologicals Sa on June 03, 2022. The current certification is valid through December 31, 2027.
How is this Glaxosmithkline Biologicals Sa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58160082415. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.